GLP1R and type 2 diabetes mellitus: There were three patients with T2DM who were able to gradually eliminate their reliance on insulin therapy and successfully transitioned to alternative treatments such as oral anti-diabetic medications or GLP1 agonists once-a-week subcutaneous injections.